Laboratory Testing for Resistant Hypertension with Palpitations
In a patient with resistant hypertension and palpitations, obtain plasma free metanephrines as the first-line test to screen for pheochromocytoma, followed by an aldosterone-to-renin ratio to evaluate for primary aldosteronism. 1
Algorithmic Approach to Testing
Step 1: Screen for Pheochromocytoma (Priority Test)
Plasma free metanephrines is the single best screening test with 99% sensitivity and 89% specificity 1. The combination of resistant hypertension with palpitations has 90% diagnostic specificity for pheochromocytoma when accompanied by headaches and sweating 1. This test should be performed first given the clinical presentation.
- Alternative option: 24-hour urine fractionated metanephrines (sensitivity ~95%) with concurrent creatinine measurement to confirm adequate collection 2
- Both plasma and urine tests perform equivalently in the absence of renal insufficiency 3
- Plasma normetanephrine is the single best parameter (89.5% sensitivity, 98.3% specificity) 4
Step 2: Screen for Primary Aldosteronism
Plasma aldosterone-to-renin ratio should be obtained as primary aldosteronism is the most common secondary cause in resistant hypertension, affecting 17-23% of these patients 1. This is critical even without hypokalemia, as only a minority present with low potassium early in disease 5.
Step 3: Consider Cushing's Syndrome Screening
Cortisol testing should be pursued if:
- Initial screens are negative but resistant hypertension persists
- Clinical features suggest hypercortisolism (central obesity, facial plethora, proximal muscle weakness, wide striae)
- Recent evidence shows 24-27% prevalence of endogenous hypercortisolism in resistant hypertension 6, 7
The most practical screening approach is overnight 1 mg dexamethasone suppression test 8.
Critical Pitfalls to Avoid
False positive metanephrines can occur with 2:
- Interfering medications (tricyclic antidepressants, decongestants, amphetamines)
- Incorrect patient positioning for plasma samples (must be supine for 30 minutes)
- Mild elevations (<2-fold upper limit of normal)
- Acute illness or hospitalization
- Only one abnormal test in a panel
Key distinction: Marked metanephrine elevations (>3 times upper limit of normal) are highly specific for pheochromocytoma and occur in only 6% of hypertensive emergencies without pheochromocytoma 9. Values this high should not be dismissed as stress-related.
Why This Testing Sequence Matters
The combination of resistant hypertension and palpitations creates a clinical scenario where missing pheochromocytoma carries severe consequences—including hypertensive crisis, stroke, myocardial infarction, and sudden death 1. Pheochromocytomas are missed in 75% of cases found at autopsy and contribute to 55% of deaths in these patients 1. The average time from symptoms to diagnosis is 3 years 1.
Primary aldosteronism, while less immediately life-threatening, causes disproportionate cardiovascular and renal damage compared to essential hypertension and requires specific aldosterone-directed therapy 7, 10.
When to Proceed with Imaging
Imaging should only be performed after biochemical confirmation 2. Proceeding directly to imaging risks identifying incidental adrenal masses (incidentalomas) that complicate rather than clarify the diagnosis.
For borderline biochemical results, repeat testing under standardized conditions or perform confirmatory tests (clonidine suppression test for pheochromocytoma) before imaging 2, 5.